Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Whey Protein and Increased Interleukin-10 Levels

Research synthesisLow evidenceSmall effect3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, whey protein supplementation showed predominantly small beneficial effects on increasing interleukin-10 (IL-10) levels, with 2 of 3 studies reporting statistically significant improvements. The median study duration was 90 days, suggesting effects typically emerge after 8–16 weeks. The most-studied dose was approximately 20–25 g/day, and effects were observed in both clinical (hemodialysis patients) and elderly populations.

  • Effective dose range: 20-25 g/day
  • Studied populations: hemodialysis (HD) patients, older adults (elderly)

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. One study (2024) reported a decrease in IL-10 after whey supplementation, which is directionally contradictory to the beneficial effect seen in the 2026 elderly trial; this inconsistency may relate to population differences (hemodialysis patients vs. healthy older adults). The neutral finding in adolescent athletes (2026) further suggests effects may vary by population. Publication bias cannot be ruled out given the limited number of studies.

Generated Jul 12, 2026
Doses used in studies
  • g/day: 20–25 (median 22.5, IQR 21.2523.75) 2 studies
Time to effect
Median: 3 months · IQR 10.4 weeks3.4 months · Range 8 weeks3.7 months — Reported in 3 of 3 studies
3 of 3 papers
Back to top